A multigene array for measurable residual disease detection in AML patients undergoing SCT

AML is a diagnosis encompassing a diverse group of myeloid malignancies. Heterogeneous genetic etiology, together with the potential for oligoclonality within the individual patient, have made the identification of a single high-sensitivity marker of disease burden challenging. We developed a multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, M, McGowan, K S, Lu, K, Jain, N, Candia, J, Hensel, N F, Tang, J, Calvo, K R, Battiwalla, M, Barrett, A J, Hourigan, C S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424111/
https://www.ncbi.nlm.nih.gov/pubmed/25665046
http://dx.doi.org/10.1038/bmt.2014.326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424111/
https://www.ncbi.nlm.nih.gov/pubmed/25665046
http://dx.doi.org/10.1038/bmt.2014.326

Ejemplares similares